|
1
|
Shiose Y, Kitazawa Y, Tsukahara S,
Akamatsu T, Mizokami K, Futa R, Katsushima H and Kosaki H:
Epidemiology of glaucoma in Japan-a nationwide glaucoma survey. Jpn
J Ophthalmol. 35:133–155. 1991.PubMed/NCBI
|
|
2
|
Weinreb RN and Khaw PT: Primary open-angle
glaucoma. Lancet. 363:1711–1720. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Crish SD and Calkins DJ: Neurodegeneration
in glaucoma: Progression and calcium-dependent intracellular
mechanisms. Neuroscience. 176:1–11. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Nickells RW: From ocular hypertension to
ganglion cell death: A theoretical sequence of events leading to
glaucoma. Can J Ophthalmol. 42:278–287. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wax MB and Tezel G: Immunoregulation of
retinal ganglion cell fate in glaucoma. Exp Eye Res. 88:825–830.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Tezel G: Immune regulation toward
immunomodulation for neuroprotection in glaucoma. Curr Opin
Pharmacol. 13:23–31. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Naert G and Rivest S: The role of
microglial cell subsets in Alzheimer's disease. Curr Alzheimer Res.
8:151–155. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wang XJ, Yan ZQ, Lu GQ, Stuart S and Chen
SD: Parkinson disease IgG and C5a-induced synergistic dopaminergic
neurotoxicity: Role of microglia. Neurochem Int. 50:39–50. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Rasmussen S, Imitola J, Ayuso-Sacido A,
Wang Y, Starossom SC, Kivisäkk P, Zhu B, Meyer M, Bronson RT,
Garcia-Verdugo JM and Khoury SJ: Reversible neural stem cell niche
dysfunction in a model of multiple sclerosis. Ann Neurol.
69:878–891. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Dagenals M, Skeldon A and Saleh M: The
inflammasome: In memory of Dr. Jurg Tschopp. Cell Death Differ.
19:5–12. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bosco A, Steele MR and Vetter ML: Early
microglia activation in a mouse model of chronic glaucoma. J Comp
Neurol. 519:599–620. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ebneter A, Casson RJ, Wood JP and Chidlow
G: Microglial activation in the visual pathway in experimental
glaucoma: Spatiotemporal characterization and correlation with
axonal injury. Invest Ophthalmol Vis Sci. 51:6448–6460. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yuan L and Neufeld AH: Activated microglia
in the human glaucomatous optic nerve head. J Neurosci Res.
64:523–532. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bosco A, Inmma DM, Steele MR, Wu G, Soto
I, Marsh-Armstrong N, Hubbard WC, Calkins DJ, Horner PJ and Vetter
ML: Reduced retina microglial activation and improved optic nerve
integrity with minocycline treatment in the DBA/2J mouse model of
glaucoma. Invest Ophthalmol Vis Sci. 49:1437–1446. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yang F, Wu L, Guo X, Wang D and Li Y:
Improved retinal ganglion cell survival through retinal microglia
suppression by a chinese herb extract, triptolide, in the DBA/2J
mouse model of glaucoma. Ocul Immunol Inflamm. 21:378–389. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Monif M, Burnstock G and Williams DA:
Microglia: Proliferation and activation driven by the P2×7
receptor. Int J Biochem Cell Biol. 42:1753–1756. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhang X, Zhang M, Laties AM and Mitchell
CH: Stimulation of P2×7 receptors elevates Ca2+ and kills retinal
ganglion cells. Invest Ophthalmol Vis Sci. 46:2183–2191. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hu H, Lu W, Zhang M, Zhang X, Argall AJ,
Patel S, Lee GE, Kim YC, Jacobson KA, Laties AM and Mitchell CH:
Stimulation of the P2×7 receptor kills rat retinal ganglion cells
in vivo. Exp Eye Res. 91:425–432. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Niyadurupola N, Sidaway P, Ma N, Rhodes
JD, Broadway DC and Sanderson J: P2×7 receptor activation mediates
retinal ganglion cell death in a human retina model of ischemic
neurodegeneration. Invest Ophthalmol Vis Sci. 54:2163–2170. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chen J, Miao Y, Wang XH and Wang Z:
Elevation of p-NR2A(S1232) by Cdk5/p35 contributes to retinal
ganglion cell apoptosis in a rat experimental glaucoma model.
Neurobiol Dis. 43:455–464. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Dong LD, Gao F, Wang XH, Miao Y, Wang SY,
Wu Y, Li F, Wu J, Cheng XL, Sun XH, et al: GluA2 trafficking is
involved in apoptosis of retinal ganglion cells induced by
activation of EphB/EphrinB reverse signaling in a rat chronic
ocular hypertension model. J Neurosci. 35:5409–5421. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Gavrieli Y, Sherman Y and Ben-Sasson SA:
Identification of programmed cell death in situ via specific
labeling of nuclear DNA fragmentation. J Cell Biol. 119:493–501.
1992. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wang X, Tay SS and Ng YK: An
immunohistochemical study of neuronal and glial cell reactions in
retinae of rats with experimental glaucoma. Exp Brain Res.
132:476–484. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Naskar R, Wissing M and Thanos S:
Detection of early neuron degeneration and accompanying microglial
responses in the retina of a rat model of glaucoma. Invest
Ophthalmol Vis Sci. 43:2962–2968. 2002.PubMed/NCBI
|
|
25
|
Ellis-Behnke RG, Jonas RA and Jonas JB:
The microglial system in the eye and brain in response to stimuli
in vivo. J Glaucoma. 22 Suppl 5:S32–S35. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Tsung A, Tohme S and Billiar TR:
High-mobility group box-1 in sterile inflammation. J Intern Med.
276:425–443. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhang N, Zhang X, Liu X, Wang H, Xue J, Yu
J, Kang N and Wang X: Chrysophanol inhibits NALP3 inflammasome
activation and ameliorates cerebral ischemia/reperfusion in mice.
Mediators Inflamm. 2014:3705302014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Dvoriantchikova G, Hernandez E, Grant J,
Santos AR, Yang H and Ivanov D: The high-mobility group box-1
nuclear factor mediates retinal injury after ischemia reperfusion.
Invest Ophthalmol Vis Sci. 52:7187–7194. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chi W, Li F, Chen H, Wang Y, Zhu Y, Yang
X, Zhu J, Wu F, Ouyang H, Ge J, et al: Caspase-8 promotes
NLRP1/NLRP3 inflammasome activation and IL-1β production in acute
glaucoma. Proc Natl Acad Sci USA. 111:pp. 11181–11186. 2014;
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Chi W, Chen H, Li F, Zhu Y, Yin W and Zhuo
Y: HMGB1 promotes the activation of NLRP3 and caspase-8
inflammasomes via NF-κB pathway in acute glaucoma. J
Neuroinflammation. 12:1372015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Xia J, Lim JC, Lu W, Beckel JM, Macarak
EJ, Laties AM and Mitchell CH: Neurons respond directly to
mechanical deformation with pannexin-mediated ATP release and
autostimulation of P2×7 receptors. J Physiol. 590:2285–2304. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Franceschini A, Capece M, Chiozzi P,
Falzoni S, Sanz JM, Sarti AC, Bonora M, Pinton P and Di Virgilio F:
The P2×7 receptor directly interacts with the NLRP3 inflammasome
scaffold protein. FASEB J. 29:2450–2461. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Murphy N, Cowley TR, Richardson JC, Virley
D, Upton N, Walter D and Lynch MA: The neuroprotective effect of a
specific P2×7 receptor antagonist derives from its ability to
inhibit assembly of the NLRP3 inflammasome in glial cells. Brain
Pathol. 22:295–306. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Pizza V, Agresta A, D'Acunto CW, Festa M
and Capasso A: Neuroinflammation and ageing: Current theories and
an overview of the data. Rev Recent Clin Trials. 6:189–203. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wang Q, Liu Y and Zhou J:
Neuroinflammation in Parkinson's disease and its potential as
therapeutic target. Transl Neurodegener. 4:192015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Lim JC, Lu W, Beckel JM and Mitchell CH:
Neuronal release of cytokine IL-3 triggered by mechanosensitive
autostimulation of the P2×7 receptor is neuroprotective. Front Cell
Neurosci. 10:2702016. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Surprenant A, Rassendren F, Kawashima E,
North RA and Buell G: The cytolytic P2Z receptor for extracellular
ATP identified as a P2X receptor (P2×7). Science. 272:735–738.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Di Virgilio F: Liaisons dangereuses:
P2X(7) and the inflammasome. Trends Pharmacol Sci. 28:465–472.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Hussen J, Düve A, Koy M and Schuberth HJ:
Inflammasome activation in bovine monocytes by extracellular ATP
does not require the purinergic receptor P2×7. Devel Comp Immunol.
38:312–320. 2012. View Article : Google Scholar
|
|
40
|
Ji M, Miao Y, Dong LD, Chen J, Mo XF,
Jiang SX, Sun XH, Yang XL and Wang ZF: Group I mGluR-mediated
inhibition of Kir channels contributes to retinal Müller cell
gliosis in a rat chronic ocular hypertension model. J Neurosci.
32:12744–12755. 2012. View Article : Google Scholar : PubMed/NCBI
|
